Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products

References

• Lovelock JE, Bishop MW. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature. 1959;183:1394–1395.
   PubMed Web of Science ®Google Scholar
• Mazur P. Principles of cryobiology. In: Barry J. Fuller, Nick Lane, Erica E. Benson, editors. Life in the frozen state. Boca Raton (FL): CRC Press; 2004. p. 3–66.
   Google Scholar
• Rowley SD. Hematopoietic stem cell cryopreservation: a review of current techniques. J Hematother. 1992;1:233–250.
   PubMedGoogle Scholar
• Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood. 1990;75:781–786.
   PubMed Web of Science ®Google Scholar
• Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998;18:4705–4708.
   PubMed Web of Science ®Google Scholar
• Sauer-Heilborn A, Kadidlo D, McCullough J. Patient care during infusion of hematopoietic progenitor cells. Transfusion. 2004;44:907–916.
   PubMed Web of Science ®Google Scholar
• Alessandrino P, Bernasconi P, Caldera D, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999;23:533–537.
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119–10122.
   PubMed Web of Science ®Google Scholar
• Berz D, McCormack EM, Winer ES, et al. Cryopreservation of hematopoietic stem cells. Am J Hematol. 2007;82:463–472.
   PubMed Web of Science ®Google Scholar
• Syme R, Bewick M, Stewart D, et al. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant. 2004;10:135–141.
   PubMed Web of Science ®Google Scholar
• Sánchez-Salinas A, Cabañas-Perianes V, Blanquer M, et al. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion. Transfusion. 2012;52:2382–2386.
   PubMed Web of Science ®Google Scholar
• Akkök CA, Holte MR, Tangen JM, et al. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells. Transfusion. 2009;49:354–361.
   PubMed Web of Science ®Google Scholar
• Saba N, Sutton D, Ross H, et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant. 1999;24:853–855.
   PubMed Web of Science ®Google Scholar
• Zenhäusern R, Tobler A, Leoncini L, et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79:523–526.
   PubMed Web of Science ®Google Scholar
• Storch E, Mark T, Avecilla S, et al. A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration. Transfusion. 2015;55:2010–2016.
   PubMed Web of Science ®Google Scholar
• Mark TM, Guarneri D, Forsberg P, et al. A phase I trial of high-dose lenalidomide and melphalan as conditioning for autologous stem cell transplantation in relapsed or refractory multiple myeloma. Biol Blood Marrow Transplant. 2017;23:930–937.
   PubMed Web of Science ®Google Scholar
• Mark TM, Reid W, Niesvizky R, et al. A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma. Biol Blood Marrow Transplant. 2013;19:831–837.
   PubMed Web of Science ®Google Scholar
• Singh AD, Parmar S, Patel K, et al. Granulocyte colony-stimulating factor use after autologous peripheral blood stem cell transplantation: comparison of two practices. Biol Blood Marrow Transplant. 2018;24(2):288–293.
   PubMed Web of Science ®Google Scholar
• Klaus J, Herrmann D, Breitkreutz I, et al. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Eur J Haematol. 2007;78:21–28.
   PubMed Web of Science ®Google Scholar
• Bensinger WI, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol. 1994;87:825–831.
   PubMed Web of Science ®Google Scholar
• Kiss JE, Rybka WB, Winkelstein A, et al. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1997;19:303–310.
   PubMed Web of Science ®Google Scholar
• Zubair A, Zahrieh D, Daley H, et al. Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution. Transfusion. 2003;43:614–621.
   PubMed Web of Science ®Google Scholar
• Shu Z, Heimfeld S, Gao D. Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion. Bone Marrow Transplant. 2014;49:469–476.
   PubMed Web of Science ®Google Scholar
• Kessinger A, Schmit-Pokorny K, Smith D, et al. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant. 1990;5 (Suppl 1):25–27.
   PubMed Web of Science ®Google Scholar
• Rowley S, MacLeod B, Heimfeld S, et al. Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components. Cytotherapy. 1999;1:311–317.
   PubMed Web of Science ®Google Scholar
• López-Jiménez J, Cerveró C, Muñoz A, et al. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant. 1994;13:789–793.
   PubMed Web of Science ®Google Scholar
• Ninan MJ, Flowers CR, Roback JD, et al. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2007;13:895–904.
   PubMed Web of Science ®Google Scholar
• Puig N, De La Rubia J, Jarque I, et al. Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation. Leuk Lymphoma. 2007;48:2367–2374.
   PubMed Web of Science ®Google Scholar
• Jantunen E, Salonen J, Juvonen E, et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol. 2004;73:174–178.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:154–163.
   PubMed Web of Science ®Google Scholar
• Post MJ, Lass-Floerl C, Gastl G, et al. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transplant Infect Dis. 2007;9:189–195.
   PubMed Web of Science ®Google Scholar